1. Home
  2. CCL vs RMD Comparison

CCL vs RMD Comparison

Compare CCL & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carnival Corporation

CCL

Carnival Corporation

HOLD

Current Price

$28.03

Market Cap

34.2B

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$253.15

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCL
RMD
Founded
1972
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
36.4B
IPO Year
1987
1995

Fundamental Metrics

Financial Performance
Metric
CCL
RMD
Price
$28.03
$253.15
Analyst Decision
Strong Buy
Buy
Analyst Count
20
12
Target Price
$35.90
$291.10
AVG Volume (30 Days)
20.8M
880.0K
Earning Date
12-19-2025
01-29-2026
Dividend Yield
2.08%
0.93%
EPS Growth
40.51
29.59
EPS
2.02
9.77
Revenue
$26,622,000,000.00
$5,257,400,000.00
Revenue This Year
$5.63
$9.85
Revenue Next Year
$3.68
$7.34
P/E Ratio
$14.32
$26.36
Revenue Growth
6.40
9.36
52 Week Low
$15.07
$199.92
52 Week High
$32.89
$293.81

Technical Indicators

Market Signals
Indicator
CCL
RMD
Relative Strength Index (RSI) 37.99 53.46
Support Level $31.35 $240.00
Resistance Level $32.47 $261.36
Average True Range (ATR) 0.89 5.40
MACD -0.51 1.27
Stochastic Oscillator 5.06 60.56

Price Performance

Historical Comparison
CCL
RMD

About CCL Carnival Corporation

Carnival is the largest global cruise company, with more than 90 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: